skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels

(2960) Views  (441) Full article downloads

Authors: Jutta Dierkes, Claus Luley, Sabine Westphal

Published Date May 2007 Volume 2007:3(1) Pages 99 - 108
DOI: http://dx.doi.org/10.2147/VHRM.S

Jutta Dierkes, Claus Luley, Sabine Westphal

Institute of Clinical Chemistry and Biochemistry, University Hospital Magdeburg, Germany

Abstract: Elevated plasma concentrations of homocysteine, a sulfur-containing amino acid, are a risk factor for coronary, cerebral and peripheral artery disease. Next to other factors, drugs used for the prevention or treatment of cardiovascular disease may modulate plasma homocysteine levels. Thus, a drug induced homocysteine increase may counteract the desired cardioprotective effect. The aim is to summarize the current knowledge on the effect of two important classes of drugs, lipid-lowering drugs and anti-hypertensive drugs, on homocysteine metabolism. Among the lipid-lowering drugs, especially the fibric acid derivatives, which are used for treatment of hypertriglyceridemia and low HDL-cholesterol, are associated with an increase of homocysteine by 20%–50%. This increase can be reduced, but not totally avoided by the addition of folic acid, vitamin B12 and B6 to fibrates. HMG-CoA reductase inhibitors (statins) do not influence homocysteine concentrations substantially. The effects of nicotinic acid and n3-fatty acids on the homocysteine concentrations are less clear, more studies are necessary to clarify their influence on homocysteine. Antihypertensive drugs have also been studied with respect to homocysteine metabolism. A homocysteine increase has been shown after treatment with hydrochlorothiazide, a lowering was observed after treatment with ß-blockers, but no effect with ACE-inhibitors. The clinical significance of the homocysteine elevation by fibrates and thiazides is not clear. However, individual patients use these drugs for long time, indicating that even moderate increases may be important.

Keywords: homocysteine, fibrates, diuretics, cardiovascular disease








Readers of this article also read:

Foot ulcers in the diabetic patient, prevention and treatment
What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: “All that is necessary for the triumph of evil is that good men do nothing?”
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Pleiotropic effects of statins in atrial fibrillation patients: the evidence
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Atorvastatin in stroke: a review of SPARCL and subgroup analysis
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University